![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
LETTERS TO THE EDITOR
Minerva Medica 2018 October;109(5):403-5
DOI: 10.23736/S0026-4806.18.05564-7
Copyright © 2018 EDIZIONI MINERVA MEDICA
lingua: Inglese
Triple therapy: worth the risk?
Bernhard WERNLY 1, Michael LICHTENAUER 1, Uta C. HOPPE 1, Alexander LAUTEN 2, Eliano P. NAVARESE 3, 4, 5, Christian JUNG 6 ✉
1 Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria; 2 Department of Cardiology, Charité - Universitaetsmedizin Berlin, University Heart Center, German Center for Cardiovascular Research (DZHK), Berlin, Germany; 3 Interventional Cardiology and Cardiovascular Medicine Research, Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA, USA; 4 SIRIO MEDICINE, Research Network, Falls Church, VA, USA; 5 Cardiovascular Institute, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; 6 Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany